Application of TCM protection field theory in treatment of tumor

WANG Zhiyi; LI Quanwang; LIN Shicheng; LI Yue; LIANG Tianyu

doi:10.16025/j.1674-1307.2024.04.019

您当前的位置：

首页 >

文章列表页 >

Application of TCM protection field theory in treatment of tumor

更新时间：2024-06-03

- Application of TCM protection field theory in treatment of tumor
- Beijing Journal of Traditional Chinese Medicine Vol. 43, Issue 4, Pages: 417-420(2024)
- 作者机构：
  
  1.北京中医药大学第二临床医学院，北京 100029
  2.北京中医药大学东方医院肿瘤科，北京 100078
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2024.04.019
  CLC：
- Published：25 April 2024，
  
  Received：31 August 2023，
扫描看全文
王郅宜，李泉旺，林事成，等.中医护场理论在肿瘤治疗中的应用［J］.北京中医药，2024，43（4）：417-420.

WANG Zhiyi,LI Quanwang,LIN Shicheng,et al.Application of TCM protection field theory in treatment of tumor[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(04):417-420.
王郅宜，李泉旺，林事成，等.中医护场理论在肿瘤治疗中的应用［J］.北京中医药，2024，43（4）：417-420. DOI： 10.16025/j.1674-1307.2024.04.019.

WANG Zhiyi,LI Quanwang,LIN Shicheng,et al.Application of TCM protection field theory in treatment of tumor[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(04):417-420. DOI： 10.16025/j.1674-1307.2024.04.019.

摘要

护场理论源于中医外科学，结合现代医学研究进展，探讨肿瘤护场的科学内涵。从护场角度认识肿瘤的侵袭与转移；治疗上在扶正祛邪治则下，强调祛邪以适度为要，勿过度追求根治，同时，利用中药内服、箍围外治等法，调动护场形成，以期为中西医结合防治肿瘤提供新思路。

Abstract

关键词

中医外科护场肿瘤

Keywords

references

SUNG H, FERLAY J, SIEGEL RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021,71(3):209-249.

江洋,刘传波,王芬,等.浅谈恶性肿瘤患者的绿色治疗模式[J].中医杂志,2019,60(15):1342-1344.

李家晗, 肖永芝. 中医外科“护场”的出处与内涵探源[J]. 中华医史杂志,2023,53(1):56-60.

王桂彬, 姜晓晨, 刘福栋,等. 疮疡理论在肿瘤治疗中的应用探讨[J]. 中医杂志,2021,62(15):1294-1298.

ZHANG S, REGAN K, NAJERA J, et al. The peritumor microenvironment: physics and immunity[J]. Trends Cancer, 2023,9(8):609-623.

安超,胡凯文,朱晓丹,等.中医“护场”理论与恶性肿瘤局部辨证的现代认识[J].中华中医药杂志,2013,28(10):3046-3049.

袁嘉玮, 李雨辰, 唐楷杰,等. 细胞竞争和肿瘤[J]. 中国细胞生物学学报,2021,43(11):2228-2234.

SUIJKERBUIJK SJ, KOLAHGAR G, KUCINSKI I, et al. Cell competition drives the growth of intestinal adenomas in drosophila[J]. Curr Biol, 2016,26(4):428-438.

GALON J, COSTES A, SANCHEZ-CABO F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome[J]. Science, 2006,313(5795):1960-1964.

SIA D, JIAO Y, MARTINEZ-QUETGLAS I, et al. Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features[J]. Gastroenterology, 2017,153(3):812-826.

XUN Z, DING X, ZHANG Y, et al. Reconstruction of the tumor spatial microenvironment along the malignant-boundary-nonmalignant axis[J]. Nat Commun, 2023,14(1):933.

CASTANEDA M, DEN HOLLANDER P, KUBURICH NA, et al. Mechanisms of cancer metastasis[J]. Semin Cancer Biol, 2022,87:17-31.

YANG L, JOSEPH S, SUN T, et al. TAK1 regulates endothelial cell necroptosis and tumor metastasis[J]. Cell Death Differ, 2019,26(10):1987-1997.

范洪桥, 刘丽芳, 熊家青,等. 从中医学角度探讨护场与恶性肿瘤的传舍[J]. 辽宁中医杂志,2019,46(9):1853-1854.

陈滨海, 张雅丽, 姚成,等. 基于肿瘤微环境学说探讨肺癌转移与痰毒的关系[J]. 中华中医药学刊,2015,33(9):2079-2081.

CHENG X, ZHANG H, HAMAD A, et al. Surgery-mediated tumor-promoting effects on the immune microenvironment[J]. Semin Cancer Biol, 2022,86(Pt 3):408-419.

濮文渊, 王梅, 凌云,等. 外科“护场”话肿瘤[J]. 时珍国医国药,2015,26(3):669-670.

BRAMAN N, PRASANNA P, WHITNEY J, et al. Association of peritumoral radiomics with tumor biology and pathologic response to preoperative targeted therapy for HER2 (ERBB2)-positive breast cancer[J]. JAMA Netw Open, 2019,2(4):e192561.

YUSA T, YAMASHITA YI, OKABE H, et al. Survival impact of immune cells infiltrating peritumoral area of hepatocellular carcinoma[J]. Cancer Sci, 2022,113(12):4048-4058.

GU Y, GUO Y, GAO N, et al. The proteomic characterization of the peritumor microenvironment in human hepatocellular carcinoma[J]. Oncogene, 2022,41(17):2480-2491.

LI H, YU J, WU Y, et al. In situ antitumor vaccination: Targeting the tumor microenvironment[J]. J Cell Physiol, 2020,235(7-8):5490-5500.

徐强, 刘婷婷, 王婉莹,等. 护场理论指导下的如意金黄散加减酊剂箍围法对皮肤脓肿大鼠组织CD68、MPO表达的影响[J]. 北京中医药大学学报,2018,41(9):771-780.

何佩珊, 刘传波, 张可睿,等. 应用“护场”理论治疗乳腺癌溃疡1例[J]. 中国中西医结合外科杂志,2013(6):712-713.

李靖华, 胡凯文, 杨丽惠,等. 胡凯文论治局部晚期乳腺癌[J]. 吉林中医药,2023,43(1):5-9.

于秀辰,孟艳娇,丁千,等.护场理论探微[J].中国中医基础医学杂志,2013,19(11):1268-1270.

黄金昶.黄金昶中医肿瘤外治心悟[M].北京:北京中医药出版社,2014:1-10.

李睿, 蔡超, 赵鹏程,等. 火针围刺联合氩氦刀冷冻消融治疗软组织肉瘤临床观察[J].上海针灸杂志,2019,38(8):874-878.

MAJEDI FS, HASANI-SADRABADI MM, THAULAND TJ, et al. Systemic enhancement of antitumour immunity by peritumourally implanted immunomodulatory macroporous scaffolds[J]. Nat Biomed Eng, 2023,7(1):56-71.

程海波, 吴勉华, 周红光. 周仲瑛从癌毒辨治恶性肿瘤的经验[J]. 北京中医药,2009,28(11):844-846.

胡凯文.肿瘤的“绿色治疗”[J].北京中医药大学学报,2013,20(4):5-7.

陈琪.不同消融范围对肺癌患者氩氦刀冷消融术临床疗效影响的研究[D].北京:北京中医药大学,2019.

庄垚雪,刘殿娜,高磊,等.不同范围冷消融治疗对Lewis肺癌小鼠Tregs细胞的影响[J].北京中医药,2023,42(3):275-280.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Strategy of modernization of anti-tumor research of traditional Chinese medicine based on Huangqin Decoction YIV 906 (PHY906)

Related Author

XU Jing

WANG Jing

WU Jie-ya

PAN Yi-ming

LI Rui-bai

LI Guang-da

HOU Li

Related Institution

北京中医药大学东直门医院血液肿瘤科

⁰